23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Arcturus Therapeutics Holdings Inc. › 2025-2026

Arcturus Therapeutics Holdings Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 10Ballot items
  • 144Asset managers, any item
  • 1,687Fund votes
  • June 5, 2026Meeting date

Results at a glance

Meeting of June 5, 2026: 10 items on Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 5, 2026: 8 elected · 2 approved.

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Arcturus Therapeutics Holdings Inc.

These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Arcturus Therapeutics Holdings Inc. — official shareholder meeting results, meeting held June 5, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. Peter Farrell 15,641,369---- 116,8955,676,925 99.3%Elected—
Elect Director: Joseph E. Payne 15,660,970---- 97,2945,676,925 99.4%Elected—
Elect Director: James Barlow 15,618,263---- 140,0015,676,925 99.1%Elected—
Elect Director: Dr. Edward W. Holmes 15,521,066---- 237,1985,676,925 98%Elected—
Elect Director: Dr. Magda Marquet 15,616,156---- 142,1085,676,925 99.1%Elected—
Elect Director: Dr. Jing L. Marantz 15,626,241---- 132,0235,676,925 99.2%Elected—
Elect Director: Dr. John H. Markels 15,633,667---- 124,5975,676,925 99.2%Elected—
Elect Director: Dr. Moncef Slaoui 15,643,492---- 114,7725,676,925 99.3%Elected—
Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement 15,254,240327,647176,375 --5,676,927 98%Approved—
Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement 21,378,01746,82310,349 ---- 99.8%Approved—

Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.

How asset managers voted at the Arcturus Therapeutics Holdings Inc. 2025-2026 meeting

144 asset managers disclosed a vote on at least one Arcturus Therapeutics Holdings Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Dr. Edward W. Holmes

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 15,521,066WITHHELD: 237,198

Prior year: 97.0% for (June 6, 2025 meeting) ▲ 1.5 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Edward W. Holmes”): 15,521,066 for, 237,198 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,470,985 for, 72,947 withheld, 258 abstained.

FOR
FOR: 7,470,985ABSTAIN: 258WITHHOLD: 72,947
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,550,8930 11,159For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds00 032,737Withhold
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X00 016,242Withhold
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments00 012,213Withhold
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Dr. Jing L. Marantz

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 15,626,241WITHHELD: 132,023

Prior year: 98.3% for (June 6, 2025 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Jing L. Marantz”): 15,626,241 for, 132,023 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,539,348 for, 4,841 withheld.

FOR
FOR: 7,539,348WITHHOLD: 4,841
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 02,389For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Dr. John H. Markels

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 15,633,667WITHHELD: 124,597

Prior year: 99.2% for (June 6, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. John H. Markels”): 15,633,667 for, 124,597 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,539,348 for, 4,841 withheld.

FOR
FOR: 7,539,348WITHHOLD: 4,841
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 02,389For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Dr. Magda Marquet

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 15,616,156WITHHELD: 142,108

Prior year: 98.3% for (June 6, 2025 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Magda Marquet”): 15,616,156 for, 142,108 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,541,665 for, 2,524 withheld.

FOR
FOR: 7,541,665WITHHOLD: 2,524
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 02,389For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Dr. Moncef Slaoui

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 15,643,492WITHHELD: 114,772

Prior year: 99.7% for (June 6, 2025 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Moncef Slaoui”): 15,643,492 for, 114,772 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,540,714 for, 3,476 withheld.

FOR
FOR: 7,540,714WITHHOLD: 3,476
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,550,8940 01,159For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Dr. Peter Farrell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 15,641,369WITHHELD: 116,895

Prior year: 98.9% for (June 6, 2025 meeting) ▲ 0.4 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Peter Farrell”): 15,641,369 for, 116,895 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,541,665 for, 2,524 withheld.

FOR
FOR: 7,541,665WITHHOLD: 2,524
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 02,389For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: James Barlow

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 15,618,263WITHHELD: 140,001

Prior year: 98.4% for (June 6, 2025 meeting) ▲ 0.7 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: James Barlow”): 15,618,263 for, 140,001 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,540,506 for, 3,683 withheld.

FOR
FOR: 7,540,506WITHHOLD: 3,683
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,548,5040 03,548For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Elect Director: Joseph E. Payne

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 15,660,970WITHHELD: 97,294

Prior year: 99.0% for (June 6, 2025 meeting) ▲ 0.4 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Joseph E. Payne”): 15,660,970 for, 97,294 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,541,665 for, 2,524 withheld.

FOR
FOR: 7,541,665WITHHOLD: 2,524
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 02,389For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 15,254,240AGAINST: 327,647

Prior year: 96.9% for (June 6, 2025 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 144 asset managers

Description as filed by funds: Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement”): 15,254,240 for, 327,647 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 52 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,552,0511 00For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century021,186 00Against
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Investment Managers Series Trust II16,3440 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For

Fund voting reports, all 52 managers: 7,539,345 for, 21,188 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 109 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Amova Asset Management Co., Ltd.2,282,6950 00For
Federated Hermes2,209,1480 00For
BlackRock604,20237 00For
Empire Life Investments Inc.383,4930 00For
Charles Schwab228,6270 00For
State Street201,6941,719 00For
HEARTLAND ADVISORS INC0171,800 00Against
Two Sigma159,0660 00For
ARK Investment Management LLC137,2220 00For
JACOBS LEVY EQUITY MANAGEMENT, INC130,7180 00For
GEODE CAPITAL MANAGEMENT, LLC123,9040 00For
Northern Trust109,772815 00For
Goldman Sachs75,8400 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/69,6940 00For
Vanguard52,1900 00For
ACADIAN ASSET MANAGEMENT LLC37,4150 00For
MELLON INVESTMENTS Corp35,9860 00For
SEI35,8370 00For
DE Shaw34,2290 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM32,1530 00For
Russell Investments31,6190 00For
AQR29,6350 00For
AllianceBernstein27,7200 00For
Green Alpha Advisors, LLC025,092 00Against
Point7223,6680 00For

Institutional-manager reports, all 109 managers: 7,240,060 for, 239,485 against. Showing the 25 largest; every one is in the interactive database (link above).

Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

99.8% Approved · of votes cast

FOR 99.8%
FOR: 21,378,017AGAINST: 46,823

Prior year: 99.9% for (June 6, 2025 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement”): 21,378,017 for, 46,823 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 7,537,388 for.

FOR
FOR: 7,537,388
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,552,0530 00For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Investment Managers Series Trust II16,3440 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

Largest Arcturus Therapeutics Holdings Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,423,069 shares outstanding at the time of that meeting.

Fund voting reports: top Arcturus Therapeutics Holdings Inc. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2025-2026
#Asset manager % of shares outstanding
1ARK ETF Trust 9.38%
2Federated Hermes 7.77%
3Vanguard 5.46%
4BlackRock 1.36%
5Charles Schwab 0.80%
6Fidelity 0.49%
7MFS 0.17%
8SEI Exchange Traded Funds 0.12%
9Equitable 0.10%
10CLEARWATER INVESTMENT TRUST 0.08%
Institutional-manager reports: top Arcturus Therapeutics Holdings Inc. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2025-2026
#Asset manager % of shares outstanding
1Amova Asset Management Co., Ltd. 8.03%
2Federated Hermes 7.77%
3BlackRock 2.13%
4Empire Life Investments Inc. 1.35%
5Charles Schwab 0.80%
6State Street 0.72%
7HEARTLAND ADVISORS INC 0.60%
8Two Sigma 0.56%
9ARK Investment Management LLC 0.48%
10JACOBS LEVY EQUITY MANAGEMENT, INC 0.46%

Reported Arcturus Therapeutics Holdings Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Arcturus Therapeutics Holdings Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Federated Hermes, Inc.3,303,640 11.62%Schedule 13G, filed January 8, 2026
BlackRock2,613,281 9.19%Form 13F, quarter ended March 31, 2026
Vanguard Group2,089,641 7.35%Form 13F, quarter ended March 31, 2026
Two Sigma1,081,784 3.81%Form 13F, quarter ended March 31, 2026
Geode Capital660,928 2.33%Form 13F, quarter ended March 31, 2026
State Street543,863 1.91%Form 13F, quarter ended March 31, 2026
Millennium Management478,557 1.68%Form 13F, quarter ended March 31, 2026
Dimensional Fund Advisors288,355 1.01%Form 13F, quarter ended March 31, 2026
D.E. Shaw252,034 0.89%Form 13F, quarter ended March 31, 2026
Northern Trust219,613 0.77%Form 13F, quarter ended March 31, 2026

Percentages above are of 28,423,069 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held June 5, 2026, in the 2025-2026 proxy season, 144 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,687 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — Arcturus Therapeutics Holdings Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Arcturus Therapeutics Holdings Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Arcturus Therapeutics Holdings (ARCT) 2026 Annual Meeting”, https://proxyvotesnow.com/company/arcturus-therapeutics-holdings-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.